GlaxoSmithKline Intellectual Property Development Limited
发明人:
Craigen, Jenny L.,Germaschewski, Fiona M.,Fieles, William E.,Mayes, Patrick A.,McCahon, Lee,Nevin (Nee Sully), Katherine,Seestaller-Wehr, Laura M.,Tunstead, James,Lee, Lydia,Paterson, Jennifer,Rodrigu
申请号：
AU2016347516
公开号：
AU2016347516A1
申请日:
2016.10.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Methods are provided for determining prognosis of multiple myeloma in a patient by measuring expression of BCMA in a sample. Also provided are methods for treating 5 multiple myeloma by measuring expression of BCMA in a sample and administering an effective amount of an antigen binding protein that binds BCMA. Also provided are kits for measuring BCMA expression in a sample.
